Invention Grant
- Patent Title: Thermostable viral reverse transcriptase
-
Application No.: US17052237Application Date: 2019-04-30
-
Publication No.: US11807667B2Publication Date: 2023-11-07
- Inventor: Thomas William Schoenfeld , Ryan Charles Heller , Katarzyna Crissy , Suhman Chung
- Applicant: QIAGEN BEVERLY, LLC
- Applicant Address: US MA Beverly
- Assignee: QIAGEN BEVERLY, LLC.
- Current Assignee: QIAGEN BEVERLY, LLC.
- Current Assignee Address: US MA Beverly
- Agency: BALLARD SPAHR LLP
- Priority: EP 173195 2018.05.18
- International Application: PCT/IB2019/053537 2019.04.30
- International Announcement: WO2019/211749A 2019.11.07
- Date entered country: 2020-11-02
- Main IPC: C12N9/12
- IPC: C12N9/12 ; C07K14/00 ; C12Q1/6844

Abstract:
The present invention provides novel engineered polypeptides that support both reverse transcription and DNA amplification in manganese-independent reactions. The present invention also provides methods for amplifying template nucleic acids using such polypeptides. This invention addresses deficiencies in the current state of the art in nucleic acid amplification-based detection of template nucleic acids, especially RNA targets, including deficiencies in detection sensitivity, specificity, enzyme stability, inhibitor tolerance and time to result compared with manganese-dependent thermostable reverse transcriptases and two-enzyme solutions.
Public/Granted literature
- US20210171580A1 THERMOSTABLE VIRAL REVERSE TRANSCRIPTASE Public/Granted day:2021-06-10
Information query